Total Funding
28
Total FundingSeries B raised
Growth Score in past quarter
pts
Heat Score 28 in past quarter
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
106357
Edico Genome revolutionizes genome sequencing analysis by providing unprecedented speed, scale, and accuracy.
- Rebecca Hemenway: Sr. Director Business Development
About the Company
Edico Genome develops bioinformatics processor chips for DNA analysis designed to analyze sequencing data. The company's DRAGEN platform uses a field-programmable gate array to provide hardware-accelerated implementations of genome pipeline algorithms, such as BCL conversion, compression, mapping, alignment, sorting, duplicate marking, and
haplotype variant calling, enabling healthcare institutions to easily discover links between DNA sequence variations and human disease.


